Insights into myelodysplastic syndromes from current preclinical models

World Journal of Hematology ◽

10.5315/wjh.v5.i1.1 ◽

2016 ◽

Vol 5 (1) ◽

pp. 1 ◽

Author(s):

ShuhYing Tan

Keyword(s):

Myelodysplastic Syndromes ◽

Preclinical Models

Download Full-text

Abstract 981: BCL-2 inhibitor APG-2575 and homoharringtonine (HHT) synergistically induces apoptosis and inhibits tumor growth in preclinical models of acute myeloid leukemia and myelodysplastic syndromes (AML/MDS)

10.1158/1538-7445.am2021-981 ◽

2021 ◽

Author(s):

Douglas D. Fang ◽

Qiuqiong Tang ◽

Yanhui Kong ◽

Tao Rong ◽

Qixin Wang ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Tumor Growth ◽

Myelodysplastic Syndromes ◽

Myeloid Leukemia ◽

Preclinical Models ◽

Download Full-text

Pexmetinib: A Novel Dual Inhibitor of Tie2 and p38 MAPK with Efficacy in Preclinical Models of Myelodysplastic Syndromes and Acute Myeloid Leukemia

Cancer Research ◽

10.1158/0008-5472.can-15-3062 ◽

2016 ◽

Vol 76 (16) ◽

pp. 4841-4849 ◽

Author(s):

Lohith Bachegowda ◽

Kerry Morrone ◽

Shannon L. Winski ◽

Ioannis Mantzaris ◽

Matthias Bartenstein ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

P38 Mapk ◽

Myelodysplastic Syndromes ◽

Myeloid Leukemia ◽

Preclinical Models ◽

Dual Inhibitor ◽

Download Full-text

Neutrophil-specific reduction in the expression of granulocyte-macrophage colony-stimulating factor receptor subunits in myelodysplastic syndromes

British Journal of Haematology ◽

10.1046/j.1365-2141.2000.02398.x ◽

2000 ◽

Vol 111 (3) ◽

pp. 863-872 ◽

Author(s):

Yayoi Shikama ◽

Tsutomu Shichishima ◽

Hitoshi Ohto ◽

Paul T. Jubinsky ◽

Keyword(s):

Myelodysplastic Syndromes ◽

Colony Stimulating Factor ◽

Macrophage Colony Stimulating Factor ◽

Macrophage Colony ◽

Stimulating Factor

Download Full-text

Review for "Epigenetic priming with decitabine followed by low dose idarubicin and cytarabine in acute myeloid leukemia evolving from myelodysplastic syndromes and higher‐risk myelodysplastic syndromes: a prospective multicenter single‐arm trial"

10.1002/hon.2755/v1/review1 ◽

2020 ◽

Keyword(s):

Acute Myeloid Leukemia ◽

Myelodysplastic Syndromes ◽

Myeloid Leukemia ◽

Low Dose ◽

Download Full-text

Decision letter for "Pulmonary Infections in Patients with Myelodysplastic Syndromes Receiving Frontline Azacytidine Treatment"

10.1002/hon.2710/v1/decision1 ◽

2019 ◽

Keyword(s):

Myelodysplastic Syndromes ◽

Pulmonary Infections

Download Full-text

Review for "Fracture healing in collagen‐related preclinical models of Osteogenesis Imperfecta"

10.1002/jbmr.3979/v1/review1 ◽

2019 ◽

Keyword(s):

Osteogenesis Imperfecta ◽

Fracture Healing ◽

Preclinical Models

Download Full-text

Decision letter for "Fracture healing in collagen‐related preclinical models of Osteogenesis Imperfecta"

10.1002/jbmr.3979/v1/decision1 ◽

2019 ◽

Keyword(s):

Osteogenesis Imperfecta ◽

Fracture Healing ◽

Preclinical Models

Download Full-text

Periosteocytic osteolysis in preclinical models

Bone Abstracts ◽

10.1530/boneabs.3.s1.1 ◽

2014 ◽

Author(s):

Alberta Zallone

Keyword(s):

Preclinical Models

Download Full-text

Acetate metabolism in Multiple Myeloma identifies11C-Acetate PET as a novel strategy to image bone disease and response to treatment in preclinical models

Bone Abstracts ◽

10.1530/boneabs.5.p122 ◽

2016 ◽

Author(s):

Francesca Fontana ◽

Xia Ge ◽

Xinming Su ◽

Jingyu Xiang ◽

Simone Cenci ◽

...

Keyword(s):

Multiple Myeloma ◽

Bone Disease ◽

Response To Treatment ◽

Acetate Metabolism ◽

Preclinical Models ◽

Download Full-text

Human medicines European public assessment report (EPAR): Vidaza, azacitidine, Myelodysplastic Syndromes, Date of authorisation: 17/12/2008, Revision: 18, Status: Authorised

Case Medical Research ◽

10.31525/cmr-3996bd ◽

2019 ◽

Author(s):

Keyword(s):

Myelodysplastic Syndromes ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text